Search

Your search keyword '"Henry, A. L."' showing total 2,105 results

Search Constraints

Start Over You searched for: Author "Henry, A. L." Remove constraint Author: "Henry, A. L." Database Unpaywall Remove constraint Database: Unpaywall
2,105 results on '"Henry, A. L."'

Search Results

11. A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 Inhibitors

15. The Discovery of 7-Isopropoxy-2-(1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-N-(6-methylpyrazolo[1,5-a]pyrimidin-3-yl)imidazo[1,2-a]pyrimidine-6-carboxamide (BIO-7488), a Potent, Selective, and CNS-Penetrant IRAK4 Inhibitor for the Treatment of Ischemic Stroke

16. Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life—Results from the Menopause after Cancer (Mac) Study

20. Supplementary material 2 from: Goetz ARB, González-Sargas E, Vidal MC, Shafroth PB, Henry AL, Sher AA (2024) Outcomes of control and monitoring of a widespread riparian invader (Tamarix spp.): a comparison of synthesis approaches. NeoBiota 91: 67-98. https://doi.org/10.3897/neobiota.91.111628

22. Supplementary material 1 from: Goetz ARB, González-Sargas E, Vidal MC, Shafroth PB, Henry AL, Sher AA (2024) Outcomes of control and monitoring of a widespread riparian invader (Tamarix spp.): a comparison of synthesis approaches. NeoBiota 91: 67-98. https://doi.org/10.3897/neobiota.91.111628

28. Assessing processing speed and its neural correlates in the three variants of primary progressive aphasia with a non-verbal tablet-based task

35. Combining working memory and speech data in a digital app for early detection of cognitive impairment in primary care

36. Combining working memory and speech data in a digital app for early detection of cognitive impairment in primary care

41. Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum

43. Supplementary Figure S4 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

44. Supplementary Methods S1 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

45. Supplementary Table S2 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

46. Supplementary Methods S2 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

47. Supplementary Figure S6 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

48. Supplementary Figure S7 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

49. Supplementary Figure S1 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

50. Supplementary Figure S3 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

Catalog

Books, media, physical & digital resources